TYK MEDICINES-B (02410) Announces Completion of H Share Full Circulation
Bulletin Express
Mar 04
TYK Medicines-B (02410) announced the completion of its H share full circulation process on March 4, 2026. According to the announcement, 4.61 million unlisted shares were successfully converted into H shares, and the newly converted shares will begin listing on the Hong Kong Stock Exchange at 9:00 a.m. on March 5, 2026.
Before this conversion, TYK Medicines-B (02410) had 375.46 million H shares (98.79% of total share capital) and 4.61 million unlisted shares (1.21%). Upon completion, TYK Medicines-B (02410) now has a total of 380.07 million H shares, representing 100.00% of its share capital. The announcement advises shareholders and potential investors to exercise caution when dealing in its H shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.